Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A Population-Based Study of Morbidity After Pancreatic Cancer Diagnosis.

Sarkar RR, Fero KE, Seible DM, Panjwani N, Matsuno RK, Murphy JD.

J Natl Compr Canc Netw. 2019 May 1;17(5):432-440. doi: 10.6004/jnccn.2018.7111.

PMID:
31085756
2.

Effect of Palliative Care on Aggressiveness of End-of-Life Care Among Patients With Advanced Cancer.

Triplett DP, LeBrett WG, Bryant AK, Bruggeman AR, Matsuno RK, Hwang L, Boero IJ, Roeland EJ, Yeung HN, Murphy JD.

J Oncol Pract. 2017 Sep;13(9):e760-e769. doi: 10.1200/JOP.2017.020883. Epub 2017 Aug 22.

3.

Unplanned 30-day hospital readmission as a quality measure in gynecologic oncology.

Wilbur MB, Mannschreck DB, Angarita AM, Matsuno RK, Tanner EJ, Stone RL, Levinson KL, Temkin SM, Makary MA, Leung CA, Deutschendorf A, Pronovost PJ, Brown A, Fader AN.

Gynecol Oncol. 2016 Dec;143(3):604-610. doi: 10.1016/j.ygyno.2016.09.020. Epub 2016 Sep 21.

PMID:
27665313
4.

Disparities in Surgical Care Among Women With Endometrial Cancer.

Mannschreck D, Matsuno RK, Moriarty JP, Borah BJ, Dowdy SC, Tanner EJ 3rd, Makary MA, Stone RL, Levinson KL, Temkin SM, Fader AN.

Obstet Gynecol. 2016 Sep;128(3):526-34. doi: 10.1097/AOG.0000000000001567.

PMID:
27500330
5.

Geographic Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing Breast Conservation for Invasive Breast Cancer.

Gillespie EF, Matsuno RK, Xu B, Triplett DP, Hwang L, Boero IJ, Einck JP, Yashar C, Murphy JD.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):251-258. doi: 10.1016/j.ijrobp.2016.05.006. Epub 2016 May 12.

6.

Patterns of Palliative Care Consultation Among Elderly Patients With Cancer.

Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN, Mell L, Murphy JD.

J Natl Compr Canc Netw. 2016 Apr;14(4):439-45.

PMID:
27059192
7.

Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer.

Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Gillespie EF, Yashar CM, Moiseenko V, Einck JP, Mell LK, Parikh SA, Murphy JD.

Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):700-8. doi: 10.1016/j.ijrobp.2015.12.018. Epub 2015 Dec 17.

PMID:
26972642
8.

Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.

French JD, Johnatty SE, Lu Y, Beesley J, Gao B, Kalimutho M, Henderson MJ, Russell AJ, Kar S, Chen X, Hillman KM, Kaufmann S, Sivakumaran H, O'Reilly M, Wang C, Korbie DJ; Australian Ovarian Cancer Study Group; Australian Ovarian Cancer Study, Lambrechts D, Despierre E, Van Nieuwenhuysen E, Lambrechts S, Vergote I, Karlan B, Lester J, Orsulic S, Walsh C, Fasching PA, Beckmann MW, Ekici AB, Hein A, Matsuo K, Hosono S, Pisterer J, Hillemanns P, Nakanishi T, Yatabe Y, Goodman MT, Lurie G, Matsuno RK, Thompson PJ, Pejovic T, Bean Y, Heitz F, Harter P, du Bois A, Schwaab I, Hogdall E, Kjaer SK, Jensen A, Hogdall C, Lundvall L, Engelholm SA, Brown B, Flanagan JM, Metcalf MD, Siddiqui N, Sellers T, Fridley B, Cunningham J, Schildkraut JM, Iversen E, Weber RP, Brennan D, Berchuck A, Pharoah P, Harnett P, Norris MD, Haber M, Goode EL, Lee JS, Khanna KK, Meyer KB, Chenevix-Trench G, deFazio A, Edwards SL, MacGregor S; Ovarian Cancer Association Consortium.

Oncotarget. 2016 Feb 9;7(6):6353-68. doi: 10.18632/oncotarget.7047.

9.

The impact of radiotherapy costs on clinical outcomes in breast cancer.

Boero IJ, Paravati AJ, Triplett DP, Hwang L, Matsuno RK, Mell LK, Murphy JD.

Radiother Oncol. 2015 Nov;117(2):393-9. doi: 10.1016/j.radonc.2015.10.004. Epub 2015 Oct 20.

10.

Variation in the Cost of Radiation Therapy Among Medicare Patients With Cancer.

Paravati AJ, Boero IJ, Triplett DP, Hwang L, Matsuno RK, Xu B, Mell LK, Murphy JD.

J Oncol Pract. 2015 Sep;11(5):403-9. doi: 10.1200/JOP.2015.005694. Epub 2015 Aug 11.

11.

Dietary isoflavone intake is not statistically significantly associated with breast cancer risk in the Multiethnic Cohort.

Morimoto Y, Maskarinec G, Park SY, Ettienne R, Matsuno RK, Long C, Steffen AD, Henderson BE, Kolonel LN, Le Marchand L, Wilkens LR.

Br J Nutr. 2014 Sep 28;112(6):976-83. doi: 10.1017/S0007114514001780.

12.

Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study.

Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, Madore J, Fereday S, George J, Galletta L, Lurie G, Wilkens LR, Carney ME, Thompson PJ, Matsuno RK, Kjær SK, Jensen A, Høgdall C, Kalli KR, Fridley BL, Keeney GL, Vierkant RA, Cunningham JM, Brinton LA, Yang HP, Sherman ME, García-Closas M, Lissowska J, Odunsi K, Morrison C, Lele S, Bshara W, Sucheston L, Jimenez-Linan M, Driver K, Alsop J, Mack M, McGuire V, Rothstein JH, Rosen BP, Bernardini MQ, Mackay H, Oza A, Wozniak EL, Benjamin E, Gentry-Maharaj A, Gayther SA, Tinker AV, Prentice LM, Chow C, Anglesio MS, Johnatty SE, Chenevix-Trench G, Whittemore AS, Pharoah PD, Goode EL, Huntsman DG, Ramus SJ.

Lancet Oncol. 2013 Aug;14(9):853-62. doi: 10.1016/S1470-2045(13)70253-5. Epub 2013 Jul 9.

13.

Type I and II endometrial cancers: have they different risk factors?

Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ; Australian National Endometrial Cancer Study Group, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV Jr, Kolonel LN, Henderson BE, Hankinson SE, Håkansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL.

J Clin Oncol. 2013 Jul 10;31(20):2607-18. doi: 10.1200/JCO.2012.48.2596. Epub 2013 Jun 3. Review.

14.

Integrated genomic characterization of endometrial carcinoma.

Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA.

Nature. 2013 May 2;497(7447):67-73. doi: 10.1038/nature12113. Erratum in: Nature. 2013 Aug 8;500(7461):242.

15.

A Community-Based Approach to Enhancing Anal Cancer Screening in Hawaii's HIV-Infected Ethnic Minorities.

Shiramizu B, Milne C, Terada K, Cassel K, Matsuno RK, Killeen J, Liang CY, Tachibana F, Sheeran T, Weihe J, Goodman MT.

J AIDS Clin Res. 2012 Aug 1;3(6). pii: 162. Epub 2012 Jul 13.

16.

Racial and ethnic variation in the incidence of small-bowel cancer subtypes in the United States, 1995-2008.

Goodman MT, Matsuno RK, Shvetsov YB.

Dis Colon Rectum. 2013 Apr;56(4):441-8. doi: 10.1097/DCR.0b013e31826b9d0a.

17.

Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium.

Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH; Australian Cancer Study (Ovarian Cancer); Australian Ovarian Cancer Study Group, Risch HA, Yu H, Doherty JA, Chang-Claude J, Hein R, Nickels S, Wang-Gohrke S, Goodman MT, Carney ME, Matsuno RK, Lurie G, Moysich K, Kjaer SK, Jensen A, Hogdall E, Goode EL, Fridley BL, Vierkant RA, Larson MC, Schildkraut J, Hoyo C, Moorman P, Weber RP, Cramer DW, Vitonis AF, Bandera EV, Olson SH, Rodriguez-Rodriguez L, King M, Brinton LA, Yang H, Garcia-Closas M, Lissowska J, Anton-Culver H, Ziogas A, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Webb PM; Ovarian Cancer Association Consortium.

Endocr Relat Cancer. 2013 Mar 22;20(2):251-62. doi: 10.1530/ERC-12-0395. Print 2013 Apr.

18.

Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository.

Matsuno RK, Sherman ME, Visvanathan K, Goodman MT, Hernandez BY, Lynch CF, Ioffe OB, Horio D, Platz C, Altekruse SF, Pfeiffer RM, Anderson WF.

Cancer Causes Control. 2013 Apr;24(4):749-57. doi: 10.1007/s10552-013-0157-5. Epub 2013 Feb 3.

19.

Polymorphisms in inflammation pathway genes and endometrial cancer risk.

Delahanty RJ, Xiang YB, Spurdle A, Beeghly-Fadiel A, Long J, Thompson D, Tomlinson I, Yu H, Lambrechts D, Dörk T, Goodman MT, Zheng Y, Salvesen HB, Bao PP, Amant F, Beckmann MW, Coenegrachts L, Coosemans A, Dubrowinskaja N, Dunning A, Runnebaum IB, Easton D, Ekici AB, Fasching PA, Halle MK, Hein A, Howarth K, Gorman M, Kaydarova D, Krakstad C, Lose F, Lu L, Lurie G, O'Mara T, Matsuno RK, Pharoah P, Risch H, Corssen M, Trovik J, Turmanov N, Wen W, Lu W, Cai Q, Zheng W, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):216-23. doi: 10.1158/1055-9965.EPI-12-0903. Epub 2012 Dec 5.

20.

Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.

Setiawan VW, Pike MC, Karageorgi S, Deming SL, Anderson K, Bernstein L, Brinton LA, Cai H, Cerhan JR, Cozen W, Chen C, Doherty J, Freudenheim JL, Goodman MT, Hankinson SE, Lacey JV Jr, Liang X, Lissowska J, Lu L, Lurie G, Mack T, Matsuno RK, McCann S, Moysich KB, Olson SH, Rastogi R, Rebbeck TR, Risch H, Robien K, Schairer C, Shu XO, Spurdle AB, Strom BL, Thompson PJ, Ursin G, Webb PM, Weiss NS, Wentzensen N, Xiang YB, Yang HP, Yu H, Horn-Ross PL, De Vivo I; Australian National Endometrial Cancer Study Group.

Am J Epidemiol. 2012 Aug 15;176(4):269-78. Epub 2012 Jul 23.

21.

Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.

Setiawan VW, Matsuno RK, Lurie G, Wilkens LR, Carney ME, Henderson BE, Kolonel LN, Goodman MT.

Cancer Epidemiol Biomarkers Prev. 2012 Sep;21(9):1441-9. doi: 10.1158/1055-9965.EPI-12-0390-T. Epub 2012 Jun 4.

22.

Genome-wide association study identifies a possible susceptibility locus for endometrial cancer.

Long J, Zheng W, Xiang YB, Lose F, Thompson D, Tomlinson I, Yu H, Wentzensen N, Lambrechts D, Dörk T, Dubrowinskaja N, Goodman MT, Salvesen HB, Fasching PA, Scott RJ, Delahanty R, Zheng Y, O'Mara T, Healey CS, Hodgson S, Risch H, Yang HP, Amant F, Turmanov N, Schwake A, Lurie G, Trovik J, Beckmann MW, Ashton K, Ji BT, Bao PP, Howarth K, Lu L, Lissowska J, Coenegrachts L, Kaidarova D, Dürst M, Thompson PJ, Krakstad C, Ekici AB, Otton G, Shi J, Zhang B, Gorman M, Brinton L, Coosemans A, Matsuno RK, Halle MK, Hein A, Proietto A, Cai H, Lu W, Dunning A, Easton D, Gao YT, Cai Q, Spurdle AB, Shu XO.

Cancer Epidemiol Biomarkers Prev. 2012 Jun;21(6):980-7. doi: 10.1158/1055-9965.EPI-11-1160. Epub 2012 Mar 16.

23.

Cataract and ovarian carcinoma: is the vitamin D hypothesis alive?

Lurie G, Matsuno RK, Wilkens LR, Thompson PJ, Ollberding NJ, Carney ME, Goodman MT.

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2507-11. doi: 10.1158/1055-9965.EPI-11-0721. Epub 2011 Oct 5.

24.

Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers.

Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu Y, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, Chang-Claude J, Nickels S, Vrieling A, Flesch-Janys D, Wang-Gohrke S, Eilber U, Bogdanova N, Antonenkova N, Runnebaum IB, Dörk T, Goodman MT, Lurie G, Wilkens LR, Matsuno RK, Kiemeney LA, Aben KK, Marees T, Massuger LF, Fridley BL, Vierkant RA, Bandera EV, Olson SH, Orlow I, Rodriguez-Rodriguez L, Cook LS, Le ND, Brooks-Wilson A, Kelemen LE, Campbell I, Gayther SA, Ramus SJ, Gentry-Maharaj A, Menon U, Ahmed S, Baynes C, Pharoah PD; kConFab Investigators; Australian Ovarian Cancer Study Group; ABCTB Investigators, Muir K, Lophatananon A, Chaiwerawattana A, Wiangnon S, Macgregor S, Easton DF, Reddel RR, Goode EL, Chenevix-Trench G; Ovarian Cancer Association Consortium.

PLoS One. 2011;6(9):e24987. doi: 10.1371/journal.pone.0024987. Epub 2011 Sep 15.

25.

Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium.

Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Carney ME, Palmieri RT, Wu AH, Pike MC, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Whittemore AS, McGuire V, Sieh W, Pharoah PD, Song H, Gronwald J, Jakubowska A, Cybulski C, Lubinski J, Schildkraut JM, Berchuck A, Krüger Kjær S, Høgdall E, Fasching PA, Beckmann MW, Ekici AB, Hein A, Chenevix-Trench G, Webb PM, Beesley J; Australian Ovarian Cancer Study Group; Australian Cancer Study Group, Goodman MT; Ovarian Cancer Association Consortium.

PLoS One. 2011;6(6):e20703. doi: 10.1371/journal.pone.0020703. Epub 2011 Jun 6.

26.

Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.

Matsuno RK, Costantino JP, Ziegler RG, Anderson GL, Li H, Pee D, Gail MH.

J Natl Cancer Inst. 2011 Jun 22;103(12):951-61. doi: 10.1093/jnci/djr154. Epub 2011 May 11.

27.

The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic white women.

Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, Weiss NS, Webb PM, Thompson PJ, Terada K, Setiawan VW, Rebbeck TR, Prescott J, Orlow I, O'Mara T, Olson SH, Narod SA, Matsuno RK, Lissowska J, Liang X, Levine DA, Le Marchand L, Kolonel LN, Henderson BE, Garcia-Closas M, Doherty JA, De Vivo I, Chen C, Brinton LA, Akbari MR; Australian National Endometrial Cancer Study Group; Epidemiology of Endometrial Cancer Consortium (E2C2), Goodman MT.

PLoS One. 2011 Feb 8;6(2):e16756. doi: 10.1371/journal.pone.0016756.

28.

Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis.

Lurie G, Wilkens LR, Thompson PJ, Matsuno RK, Carney ME, Goodman MT.

Gynecol Oncol. 2010 Nov;119(2):278-84. doi: 10.1016/j.ygyno.2010.05.028. Epub 2010 Jun 29.

29.

Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.

Figueroa JD, Flanders KC, Garcia-Closas M, Anderson WF, Yang XR, Matsuno RK, Duggan MA, Pfeiffer RM, Ooshima A, Cornelison R, Gierach GL, Brinton LA, Lissowska J, Peplonska B, Wakefield LM, Sherman ME.

Breast Cancer Res Treat. 2010 Jun;121(3):727-35. doi: 10.1007/s10549-009-0590-z. Epub 2009 Nov 24.

30.

Qualitative age interactions between low-grade and high-grade serous ovarian carcinomas.

Grimley PM, Matsuno RK, Rosenberg PS, Henson DE, Schwartz AM, Anderson WF.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2256-61. doi: 10.1158/1055-9965.EPI-09-0240. Epub 2009 Jul 21. Erratum in: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2803.

31.

Racial differences in breast cancer trends in the United States (2000-2004).

Pfeiffer RM, Mitani A, Matsuno RK, Anderson WF.

J Natl Cancer Inst. 2008 May 21;100(10):751-2. doi: 10.1093/jnci/djn112. Epub 2008 May 13. No abstract available.

PMID:
18477805
32.

Hairy cell leukaemia: a heterogeneous disease?

Dores GM, Matsuno RK, Weisenburger DD, Rosenberg PS, Anderson WF.

Br J Haematol. 2008 Jul;142(1):45-51. doi: 10.1111/j.1365-2141.2008.07156.x. Epub 2008 May 8.

33.

Shifting breast cancer trends in the United States.

Anderson WF, Reiner AS, Matsuno RK, Pfeiffer RM.

J Clin Oncol. 2007 Sep 1;25(25):3923-9. Epub 2007 Aug 6.

PMID:
17679726
34.

Early- and late-onset breast cancer types among women in the United States and Japan.

Matsuno RK, Anderson WF, Yamamoto S, Tsukuma H, Pfeiffer RM, Kobayashi K, Devesa SS, Levine PH.

Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1437-42.

35.

Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions.

Anderson WF, Matsuno RK, Sherman ME, Lissowska J, Gail MH, Brinton LA, Yang XR, Peplonska B, Chen BE, Rosenberg PS, Chatterjee N, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Devesa SS, García-Closas M.

Cancer Causes Control. 2007 May;18(4):439-47. Epub 2007 Jan 9.

PMID:
17216325

Supplemental Content

Loading ...
Support Center